708 Petticrew, Mark, Bell, Ruth and Hunter, Duncan, 2002. Influence of psychological coping on survival and recurrence in people with cancer: systematic review. BMJ , 325, 1066–1069.
709 Graham, J, Ramirez, A, Love, S, Richards, M and Burgess, C. 2002. Stressful life experiences and risk of relapse of breast cancer: observational cohort study. BMJ , 324, 1420–1422.
710 Beales, D., 2004. Beyond mind-body dualism: implications for patient care. Journal of Holistic Healthcare , 1 (3).
711 Ernst, Edzard (ed.), 2001. The desktop guide to complementary and alternative medicine. Mosby.
712 King, Michael and five others, 2002. Effectiveness of teaching general practitioners skills in brief cognitive behaviour therapy to treat patients with depression: randomised controlled trial. BMJ , 324, 947.
714 European Journal of Cancer , 2003, 39, 1562–1567; quoted in BMJ , 327, 402.
715 Plant, Jane and Stephenson, Janet, in preparation. Breakthrough Anxiety and Depression .
716 Bartram, Thomas, 1998. Bartram's Encyclopedia of Herbal Medicine . London: Robinson.
717 Miller, G H, 1996. Can Active or Passive Smoking Increase Breast Cancer Mortality? Cancer Detect Prevent 20 (5).
718 Mayor, Susan. 2002. Pregnancy and early smoking increases breast cancer risk. BMJ , 325, 12 October 2002, 793.
719 Cancer Epidemiology, Biomarkers and Prevention , July 2003; http://www.nlm.nih.gov/medlineplus/news/fullstory_13352.html
720 Plant, Jane and Tidey, Gill, 2003. Understanding, preventing and overcoming osteoporosis . Virgin Books.
721 Goodman-Gruen, D. and Barrett-Connor, E., 1997. Epidemiology of insulin-like growth factor-I in elderly men and women. The Rancho Bernardo Study. American Journal of Epidemiology , 145, 970–976; Kaklamani, V.G., Linos, A., Kaklamani E., Markaki, I. and Mantzoros, C., 1999. Age, sex, and smoking are predictors of circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3. Journal of Clinical Oncology , 17. 813–817.
722 Colborn, T., Dumanoski, D. and Myers, J.P., 1996. Our Stolen Futures , Dutton, Penguin Books, USA.
723 The Environment Agency, March 2000. Endocrine-disrupting substances in the environment: The Environment Agency's Strategy, The Environment Agency, Bristol, UK.
725 Miller, W.R. and Sharpe, R.M., 1998. Environmental oestrogens and human reproductive cancers. Endocrine-Related Cancer , S, 69–96; Plant, J.A. and Davis, D.L., 2003. Breast and prostate cancer: sources and pathways of endocrine-disrupting chemicals (EDCs). In Geology and Health . Skinner, H.C.W. and Berger, A.R. (editors). OUP. 95–99.
726 McKinlay, R. and others, in press. Endocrine disrupting pesticides: implications for risk assessment.
727 Toppari, J., Larsen, J.C., Christiansen, P., Giwercman, A., Grandjean, P., Guillette, L-J., Jr, Jegou, B., Jensen, T.K., Jouannet, P., Keiding, N., Leffers, H., McLachlan, J.A., Meyer, O., Muller, J., Rajpert-De Meyts, E., Scheike, T., Sharpe, R.M., Sumpter, J.S., and Skakkebaek, N.E., 1996. Male reproductive health and environmental xenoestrogens. Environmental Health Perspectives , 104, 741–803.
729 The Royal Commission on Environmental Pollution, 2003. Chemicals in products: safeguarding the environment and human health. Report 24; Annual Reports of the (UK) Chemical Stakeholders Forum, 2002, and The Advisory Committee on Hazardous Substances, 2002; Miller, W.R. And Sharpe, P.M., 1998. Environmental oestrogens and human reproductive cancers. Endocrine-Related Cancer , 5, 69–96.
730 Charlier, C.C.J., 2002. Determination of organochlorine pesticide residues in the blood of healthy individuals. Clinical Chemistry and Laboratory Medicine , 44, 361–364; WWF, 2003. UK national biomonitoring survey . WWF.
731 MDuffie, H.H., 2005. Host factors and genetic susceptibility: a paradigm of the conundrum of pesticide exposure and cancer associations. Reviews on Environmental Health . 20 (2), 77-101.
732 Mathur, V., 2002. Breast cancer incidence and exposure to pesticides among women originating from Jaipur. Environment International , 28 (5), 331–336; Starek, A., 2003. Estrogen and organochlorine xenoestrogens and breast cancer risk. International Journal of Occupational Medicine and Environmental Health . 16 (2), 113–124.
733 Frigo, D.E., 2004. Mechanism of AP-1-mediated gene expression by select organochlorines through the p38 MAPK pathway. Carcinogenesis , 25 (Feb), 249–261; Lewis, J.S. and others, 2005. Differential effects of 16-hydroxyestrone and 2-methoxyestradiol on cyclin D1 involving the transcription factor ATF-2 in MCF-7 breast cancer cells. Journal of Molecular Endocrinology , 34, 91-105; Tessier, D.D., 2001. Increased ErbB-2 tyrosinekinase activity, MAPK phosporylation, and cell proliferation in the prostate cancer cell line LNCaP following treatment by select pesticides. Toxicological Sciences . 60 (1), 38–43.
734 Swan S.H. and others, 2005. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environmental Health Perspectives , 113, (8).
735 Kawauchi, H., 2002. Identifi cation of growth hormone in the sea lamprey, an extant representative of a group of the most ancient vertebrates. Endocrinology , 143 (12), 4916–4921; Park, J.I., 2005. Conservation of the heterodimeric glycoprotein hormone subunit family proteins and the LGR signalling system from nematodes to humans. Endocrine Journal , 26 (3), 267–276.
736 Environmental Endocrine Disruptors: A Handbook of Property Data, John Wiley and Sons.
737 Edwards, T.T., 2006. Reproductive dysgenesis in wildlife: a comparative view. International Journal of Andrology , 29 (1), 109–121; Guillette, L.L., 1999. Plasma steroid concentrations and male phallus size in juvenile alligators from seven Florida lakes. General and Comparative Endocrinology , 116(3), 356–372.
738 Colborn, T., Dumanoski, D. and Myers, J.P., 1996. Our Stolen Futures , Dutton, Penguin Books, USA.
739 Webb, S.F., 2000. Risk assessment approaches for Pharmaceuticals. In: International Seminar: Pharmaceuticals in the Environment, Technological Institute, Section on Environmental Technology, Brussels, 2000.
740 Kolpin, D.A., Furlong, E.T., Meyer, M.T., Thurman, E.M., Zaugg, S.D., Barber, L.B. and Buxton, H.T.; 2002. Pharmaceuticals, Hormones, and Other Organic Wastewater Contaminants in US Streams, 1999–2000: A National Reconnaissance. Environmental Science & Technology , 36, 1202–1211.
741 McQuillan, D., Mullany, J., Parker, J., Mills, D., Sherrell, K. and Chapman, T.H., 2000. Drug Residues in Ambient Water: Initial Surveillance in New Mexico, USA. December 2000 Progress Report, http://www.nmenv.state.nm.us/gwb/drugs.html; Morelli, J., 2000. Are Our Medicines Tainting the Environment? http://webmd.lycos.com/content/article/25/1728_58159?
742 McQuillan, D., Mullany, J., Parker, J., Mills, D., Sherrell, K. and Chapman, T.H., 2000. Drug Residues in Ambient Water: Initial Surveillance in New Mexico, USA. December 2000 Progress Report, http://www.nmenv.state.nm.us/gwb/drugs.html
743 The Royal Commission on Environmental Pollution, 2003. Chemicals in products: safeguarding the environment and human health. Report 24.
744 Hamburger Umwelt Institute, 1997. Poor Design Practices – gaseous emissions form complex products.
745 Brown, S.K. and Cheng, M., 2000. Volatile Organic Compounds (VOCs) in New Car Interiors. Presented at the 35th International Clean Air & Environment Conference Sydney, 26–30 November 2000.
747 Clapp, R.W. and others, 2005. Environmental and occupational causes of cancer . The Lowell Centre for Sustainable Production, University of Massachusetts Lowell.
748 The Globe and Mail, November 22, 2002, page A5. Data point to breast-cancer risk. By Martin Mittelstaedt.
749 Newby, J.A. and Howard, C.V., 2006. Environmental influences in cancer aetiology. Journal of Nutritional and Environmental Medicine; 2006, 1-59.
750 Clapp, R.W. and others, 2005. Environmental and occupational causes of cancer . The Lowell Centre for Sustainable Production, University of Massachusetts Lowell.
751 Birnbaum, L.S. and Fenton, S.E., 2003. Cancer and developmental exposure to endocrine disruptors. Environmental Health Perspectives , 11 (4), 389–395.
756 Spurgeon, D., 2006. Vitamin D is associated with a lower risk of cancer. BMJ , 332, 70.
757 Miller, W.R. and Sharpe, R.M., 1998. Environmental oestrogens and human reproductive cancers. Endocrine-Related Cancer , 5, 69–96.
759 Gottlieb, Scott. 2002. Study supports evidence on oral contraception and breast cancer. BMJ , 325, 6 July 2002, 8.
760 Writing Group for the Women's Health Initiative Investigators. 2002. Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women. Journal of the American Medical Association , 288, № 3.
761 Collaborative Group on Hormonal Factors in Breast Cancer, 1997. Breast cancer and hormone replacement therapy. Lancet , 350, 1047–1059.
762 Schairer, C., Lubin, J., Troisi, R., and others, 2000. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA , 283(4), 485–491.
764 Ross, R.K., Paganini-Hill, A., Wan, P.C. and others, 2000. Effective hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J. Natl Cancer Inst , 92, 328–332. Schairer, C., Lubin, J., Troisi, R. and others. 2000. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA , 283 (4), 485–491.
765 The Times . 15 December 2006.
766 Ernst, E (editor), 2001. The Desktop Guide to Complementary and Alternative Medicine: an evidence based approach. Mosby.
767 Lee, John R, 1999. Natural Progesterone . Second revised edition. Jon Carpenter.
768 Cowan, L.D., Gordis, L., Tonascia, J.A. and Jones, G.S., 1981. Breast cancer incidence in women with a history of progesterone deficiency. Am. J. Epidemiology , 114, 209–217.
769 Hrushesky, W.J.M., 1996. Breast cancer, timing of surgery, and the menstrual cycle: call for prospective trial. J. Women's Health , 5, 555–566.
770 Mohr, P.E., Wang, D.Y., Gregory, W.M., Richards, M.A. and Fentiman, I.S., 1996. Serum progesterone and prognosis in operable breast cancer. British J. Cancer , 73, 1552–1555.
771 Butler, J., 2006. White lies . Vegetarian and Vegan Foundation.
772 Dibble, S.L. and others, 2002. Risk factors for ovarian cancer; lesbian and heterosexual women. Oncol Nursing Forum , 29 (1), El-7.
773 Ives, A. and Semmens, J., 2007. Pregnancy after breast cancer: population based study. BMJ , 334, 194.
778 Campbell, T., Colin, Campbell, Thomas M. II, Robbins, John and Lyman Howard, 2006. The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Health, Benbella Books.
779 Kannel W.B. and others, 1961. Factors of risk in the development of coronary heart disease – six year follow up experience. Anna. Internal medi ., SS.
780 Campbell, T. Colin, Campbell, Thomas M. II, Robbins, John and Lyman Howard, 2006. The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Health, Benbella Books.
781 Campbell, T.C. and Junshi, C., 1994. Diet and chronic degenerative disease perspectives from China. American Journal of Clinical Nutrition , 59 (Suppl.), 11 535–11 615.
783 Campbell, T. Colin, Campbell, Thomas M. II, Robbins, John and Lyman Howard, 2006, The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Health, Benbella Books.
784 Schlosser, Eric, 2002. Fast Food Nation . Penguin Books.
785 Martin, Peter, 2002. Milk: Nectar or Poison? Sunday Times Magazine , 21 July 2002, 46–54.
786 Mercer, Chris, 2007. EU unveils milk shake-up plans, www.foodnavigator.com
788 Butler, J., 2006. White lies . Vegetarian and Vegan Foundation.
808 Parry, Vivienne, 2007. It's udder confusion. The Times (Body and Soul) . 20 January 2007.
809 Butler, Justine, 2007. Second opinion. The Times (Body and Soul) , 27 January 2007.
810 ICON , 2006, issue 4.
811 Bristow, A., 2002. Organic processed food. Which? April 2002, 22–23.
812 Martin, Peter, 2002. Milk: Nectar or Poison? Sunday Times Magazine , 21 July 2002. 46–54.
813 Bristow, A., 2002. Organic processed food. Which? April 2002, 22–23.
814 Inside Story. Which? April 2002, 4.
815 Clapp, R.W., Howe, K.H, and Jacobs, M.M., 2005. Environmental and occupational causes of cancer, www.sustainableproduction.org
816 Plant, J.A., Turner, K.T., and Highley, D.E., 1998. Minerals and the environment. Proceedings of Minerals '98 Conference, June 1998: Republished in the Mineralogical Society Bulletin , No. 119, July 1998, 3–11; Mineral Planning 77, December 1998, 3–8; IM&M Journal , December 1998, 1, 12, 331–336.
817 Kushi L.H. and others, 2007. Lifestyle factors and survival in women with breast cancer. The Journal of Nutrition , Special supplement; Intern. Research conf. on food, nutrition and cancer, 236S-242S.
818 Getz, Linn, Sigurdsson, Johann A. and Hetlevik, Irene, 2003. Is opportunistic disease prevention in the consultation ethically justifiable? BMJ , 327, 498.
819 Research muddled by political pressures. The Times (Public Agenda) , 19 August 2003.
820 Chaturvedi, P., 2003. Medical community may be partly responsible for cancer misery. BMJ , 326, 1146.
821 Kmietowicz, Zosia, 2002. Research spending on cancers doesn't match their death rates. BMJ , 325, 920.
822 Smith, Richard, 2003. Do patients need to read research? BMJ , 326, 3307.
823 Smith, Richard, 2003. Do patients need to read research? BMJ , 326, 1307.
824 Corrie, Pippa, Shaw, Justin and Harris, Roy, 2003. Rate limiting factors in recruitment of patients to clinical trials in cancer research: descriptive study. BMJ , 327, 320–321.
825 Wald, Nicholas J. and Morris, Joan K… 2003. Teleoanalysis: combining data from different types of study. BMJ , 327, 616–618.
826 The Times (Public Agenda), 6 March 2007.
827 Smith, Richard, 2003. Editor's choice: The screening industry. BMJ , 326, 26 April 2003.
828 Lechin, Fuard and others, 2002. Neurocircuitry and Neuroautonomic Disorders . Karger.
829 Gottlieb, Scott, 2003. US drug sales continue to rise. BMJ , 326, 518.
831 Kjaergard, Lise L. and Als-Nielsen, Bodily 2002. Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ. BMJ , 325, 249–252.
832 Eaton, Lynn, 2003. Readers want transparency in link between doctors and drug firms. BMJ , 326, 1352.
833 Mayor, Susan, 2002. Researchers claim clinical trials are reported with misleading statistics. BMJ , 324, 1353.
834 JAMA , 2003, 389, 454–465, quoted by Hopkins Tanne, Janice, 2003. Industry is deeply involved in funding US research. BMJ , 326, 179.
835 Tonks, Alison, 2002. Authors of guidelines have strong links with drugs industry. BMJ , 324, 383.
836 Spurgeon, David, 2002. Doctors accept $50 a time to listen to drug representatives. BMJ , 324, 1113.
837 Gottlieb, Scott, 2003. A fifth of Americans contact their doctor as a result of direct to consumer drug advertising. BMJ , 325, 854.
838 BMJ , 2003. Drug companies want to inform patients. BMJ , 326, 1286.
839 Watson, Rory, 2003. EU health ministers reject proposal for limited direct to consumer advertising. BMJ , 326, 1284.
840 Watson, R., 2006. Cancer group denies company funding will influence its agenda. BMJ , 333, 874.
841 Mayor, Susan, 2002. GMC issues new guidance on clinical research. BMJ , 324, 384.
842 Marwick, Charles, 2002. US tackles drug company gifts to doctors. BMJ , 325, 795.
843 Mosconi, Paola, 2003. Declaration of competing interests is rare in Italian breast cancer associations. BMJ , 327, 344.
844 Herxheimer, A., 2003. Relationships between the pharmaceutical industry and patients' organisations. BMJ , 326, 1208–1210.
845 Hirst, J., 2003. Charities and patient groups should declare interests. BMJ , 326, 1211.
846 Clark, Jocalyn, 2003. A hot flush for Big Pharma. BMJ , 327, 400.
847 Writing Group for the Women's Health Initiative Investigators, 2002. Risks and benefi ts of estrogen plus progestin in healthy postmenopausal women. JAMA , 288, 321–333.
848 The Times , 15 December 2006.
849 Moynihan, Ray, 2003. US seniors group attacks pharmaceutical industry 'fronts'. BMJ , 326, 351.
850 Cho, E, and others, 2006. Red meat intake and risk of breast cancer among premenopausal women. Archivesof International Medicine , 166, 2253–2259.
851 Lenzer, Jeanne, 2002. The operation was a success (but the patient died). BMJ , 325, 664.
859 Campbell, T, Colin, Campbell, Thomas M. II, Robbins, John and Lyman Howard, 2006. The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Health. Benbella Books.
860 Robbins, John, 1987. A Diet for a New America . Stillpoint.
861 Butler, J., 2006. White lies . Vegetarian and Vegan Foundation.